September 1, 2020 - Masimo (Irvine, CA) announced that O3 Regional Oximetry has received FDA clearance for expanded use in monitoring somatic tissue oxygenation saturation in all patient populations and monitoring relative changes in hemoglobin, oxyhemoglobin, and deoxyhemoglobin in adult brains. This clearance means that O3 is now indicated for use in both … [Read more...]
New studies investigate accuracy of noninvasive, continuous hemoglobin monitoring with Masimo SpHb on neonates
August 20, 2020 - Masimo announced that, in a study recently published in the Journal of Tropical Pediatrics, researchers evaluating Masimo SpHb (noninvasive, continuous hemoglobin monitoring) on neonatal patients concluded that the technology “offers reliable Hb [hemoglobin] values, which are comparable with the more traditional tHb [invasive venous blood … [Read more...]
Masimo PVi receives FDA clearance as indicator of fluid responsiveness on mechanically ventilated patients
August 17, 2020 - Masimo (Irvine, CA) announced that PVi (pleth variability index) has received FDA clearance as a continuous, noninvasive, dynamic indicator of fluid responsiveness in select populations of mechanically ventilated adult patients. PVi, is a measure of the dynamic changes in perfusion index that occur during the respiratory cycle. Available alongside Masimo … [Read more...]
Masimo: New study shows greater depth of patient sedation than intended during procedural colonoscopy
August 04, 2020 - Masimo (Irvine, CA) announced that, in a new study published in Anesthesia Research and Practice, researchers used Masimo SedLine Brain Function Monitoring to investigate the depth of anesthesia of patients receiving propofol for outpatient colonoscopy. The role of anesthesiologists in keeping patients appropriately sedated, and not over- or … [Read more...]
Masimo teams up with the NBA as official supplier of pulse oximetry
July 31, 2020 – Masimo (Irvine, CA) has entered into a partnership with the National Basketball Association (NBA) to be the league’s official supplier of pulse oximetry. As teams return to play, Masimo is supplying the NBA with MightySat fingertip pulse oximeters on its campus in Orlando, Florida. Since arriving on campus in Orlando on July 7, and for the duration of their … [Read more...]
Masimo introduces new Radius T° to Masimo SafetyNet platform
July 28, 2020 - Masimo (Irvine, CA) announced a significant expansion to the Masimo SafetyNet platform with the introduction of Radius T°, a wearable, wireless sensor that provides continuous body temperature measurements. By augmenting the Masimo SafetyNet with Radius T°, the remote patient management solution becomes capable of tracking four key vital signs – oxygen … [Read more...]
Masimo announces new evidence demonstrating benefits of critical congenital heart disease (CCHD) screening using SET Pulse Oximetry
July 21, 2020 – Masimo (Irvine, CA) announced the results of a prospective study published in the International Journal of Neonatal Screening in which researchers in Marrakesh, Morocco conducted the first Moroccan study on critical congenital heart disease (CCHD) screening for newborns using Masimo SET pulse oximetry. The authors concluded that "Our results encourage us to … [Read more...]
Masimo announces UniView: 60 Digital Charting Solution
Masimo (Irvine, CA) announced its latest automation and connectivity solution, UniView: 60. UniView: 60 uses the Masimo Hospital Automation platform to aggregate and display pertinent patient information on a digital display outside each patient's room, allowing clinicians to familiarize themselves with the most relevant details of each patient’s case at the door in 60 seconds … [Read more...]
Study investigates accuracy of respiration rate obtained from Pulse Oximetry on pediatric patients using Masimo RRp
Masimo (Irvine, CA) announced the results of a study published in Pneumonia in which independent researchers in New Delhi, India, investigated the accuracy of Masimo RRp on pediatric patients with the Rad-G Pulse Oximeter by comparing it to clinician-determined values while performing routine assessment of children admitted to outpatient and emergency departments. The … [Read more...]
Masimo announces Bridge™
Masimo (Irvine, CA) announced Bridge™, an opioid withdrawal solution that uses neuromodulation to aid in the reduction of symptoms associated with opioid withdrawal. Bridge, which has been granted an FDA De Novo classification, is the first evidence-based, drug-free, non-surgical device of its kind. In clinical testing, Bridge was found to reduce opioid withdrawal symptoms … [Read more...]